Genetics Co. Inks $1.4B Deal With Cooley-Led Cancer Tech Biz
Invitae, a genetics company that tests for rare and genetic diseases, said Monday that it has inked a $1.4 billion deal to merge with cancer-focused genetic testing technology provider ArcherDX, which...To view the full article, register now.
Already a subscriber? Click here to view full article